Myconic Capital / Ketamine One Acquires Integrated Rehab and Performance Ltd.
April 23, 2021
Myconic Capital Corp. (MEDI) entered into a letter of intent to acquire 100% of Integrated Rehab and Performance Ltd. (IRP), a Victoria, British Columbia multidisciplinary physical therapy clinic that specializes in care for veterans, RCMP and first responders. The transaction contemplates payment in MEDI common shares, retention of IRP's CEO, and the introduction of ketamine-assisted therapies and expansion of IRP's clinic network in British Columbia; subsequent press releases indicate Ketamine One signed and closed a definitive agreement to acquire IRP.
- Buyers
- Myconic Capital Corp., Ketamine One Inc.
- Targets
- Integrated Rehab and Performance Ltd.
- Industry
- Healthcare Services
- Location
- British Columbia, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Integrated Rehab Consultants Acquires Integrative Physiatry
June 6, 2022
Healthcare Services
Integrated Rehab Consultants (a portfolio company of Webster Equity Partners) has acquired Integrative Sports and Spine, Inc. (operating as Integrative Physiatry), a California-based national physiatry practice. The add-on expands IRC's west coast footprint and scales its post-acute physiatry capabilities—Integrative Physiatry operates ~50 physiatrists across roughly 100 skilled nursing facilities.
-
Champignon Brands Acquires AltMed Capital Corp.
April 9, 2020
Healthcare Services
Champignon Brands Inc. has entered into a definitive agreement to acquire 100% of AltMed Capital Corp., a Canadian ketamine clinic operator and psychedelic medicine IP aggregator that owns a majority stake in the Canadian Rapid Treatment Centre of Excellence (CRTCE) in Mississauga. The acquisition gives Champignon clinic SOPs, Health Canada-approved psilocybin dosing capability, existing IP and an early-stage clinical trials portfolio to accelerate its psychedelic medicine and rapid-onset treatment rollout in Canada and the United States.
-
Delic Holdings Acquires Ketamine Infusion Centers LLC
December 7, 2020
Healthcare Services
Delic Holdings Inc. (DELIC) entered into an agreement to acquire all membership interests of Ketamine Infusion Centers LLC (KIC), an operator of two ketamine infusion clinics in Phoenix, Arizona and Bakersfield, California. The transaction (structured as a reverse triangular merger) expands DELIC's psychedelic wellness platform by adding physical clinic operations and a team of medical professionals, with consideration primarily issued as DELIC subordinate voting shares and contingent milestone shares.
-
Revive Therapeutics Agrees to Acquire Psilocin Pharma Corp.
February 11, 2020
Pharmaceuticals
Revive Therapeutics Ltd. entered into a letter of intent to acquire all issued and outstanding securities of Psilocin Pharma Corp. for an aggregate purchase price of $2.75 million to be satisfied by issuing 55 million common shares of Revive (deemed $0.05/share). Revive deposited 10 million shares ($500,000) into escrow as a deposit; the closing is subject to due diligence and execution of a definitive share exchange agreement.
-
Integrated Rehab Consultants Acquires National Health Rehabilitation
October 26, 2021
Healthcare Services
Integrated Rehab Consultants (IRC), a portfolio company of Webster Equity Partners, has acquired National Health Rehabilitation (NHR), a national physiatry practice founded by Drs. Nitin Putcha and Amishi Dharia. The add-on strengthens IRC’s physiatry services in skilled nursing facilities and hospitals and increases geographic density—particularly in the Northeast—across IRC’s national footprint.
-
ProPharma Group Acquires Kateric
September 1, 2022
Healthcare Services
ProPharma Group, an Odyssey Investment Partners–backed provider of regulatory, clinical, and compliance services, has acquired Kateric, a medical writing firm founded in 2004. The deal expands ProPharma's medical writing capabilities and brings Kateric's leadership and global writing resources into ProPharma's portfolio.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.